You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):子公司參與的聯合體獲得新獸藥註冊證書
格隆匯 08-02 16:44

格隆匯8月2日丨海利生物(603718.SH)公吿,根據有關規定,經中華人民共和國農業農村部審查,准予公司全資子公司山東海利生物製品有限公司與其他單位聯合申報的“副豬嗜血桿菌病三價滅活疫苗(4型H4L1株+5型H5L3株+12型H12L3株)”為新獸藥,並核發了《新獸藥註冊證書》。

該藥用於預防由血清4型、血清5型和血清12型副豬嗜血桿菌引起的副豬嗜血桿菌病。免疫期為6個月。

該新獸藥證書的取得是公司持續重視科技創新的結果,推動了公司產品的升級、豐富了公司豬類細菌疫苗產品結構,有助於提升公司服務我國養豬業的能力,提高我國豬病防控水平,進而減少抗生素使用量。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account